Sign inGet started

Luke Thomas Charles

Insider CIK 1889689 · SABS Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SABS SAB Biotherapeutics, Inc. A Award deriv2022-03-162022-03-1820,519— $020,519SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-26139,585— $0139,585SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-2611,632— $011,632SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-2661,092— $061,092SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-262,193— $02,193SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-10-222021-10-265,428— $05,428SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-10-192021-10-26990$10.10 $10.0K990SEC↗